Oxime derivatives of betulonic and platanic acid as novel cytotoxic or antiviral agents

Lucie Cerna,Uladzimir Bildziukevich,Lucie Rárová,Jana Trylcova,David Šaman,Jan Weber,Petra Lovecka,Zdenek Wimmer
DOI: https://doi.org/10.1039/d4re00032c
IF: 5.2002
2024-02-13
Reaction Chemistry & Engineering
Abstract:Less frequently studied betulonic and platanic acid, plant triterpenoids, were selected to design, synthesize and investigate their oxime derivatives as novel and potentially effective cytotoxic and/or antiviral agents. The target compounds were subjected to the cytotoxicity screening tests in several human cancer cell lines. Several of them displayed cytotoxicity in T-lymphoblastic leukemia (CCRF-CEM), breast adenocarcinoma (MCF7), malignant melanoma (G-361) and cervical cancer (HeLa) cell lines. Betulonic acid oxime (3) displayed cytotoxicity in CCRF-CEM (IC50 = 18.9 ± 1.1 μM; SI = 2.4) and G-361 (IC50 = 21.3 ± 2.8 μM; SI = 2.2) cancer cell lines. Benzyl ester of platanic acid oxime (17) displayed an anti-HIV-1 effect (EC50 = 3.2 ± 0.43 μM; SI > 31) and no anti-HSV-1 effect (EC50 > 100 μM), while platanic acid oxime (15) showed lower effects, EC50 = 36 ± 4.0 μM (HIV-1) and EC50 = 48 ± 6.0 μM (HSV-1), respectively. Compound 17 showed high selectivity in antiviral effects, being effective in HIV-1 and inactive in HSV-1. A side product 18 showed antiviral activity with EC50 = 15 ± 1.3 μM (HIV-1), and EC50 = 12 ± 0.21 μM (HSV-1), while another side product 19 was cytotoxic in HeLa (IC50 = 24.5 ± 1.8 μM).
chemistry, multidisciplinary,engineering, chemical
What problem does this paper attempt to address?